Abstract
The International Association for the Study of Lung Cancer (IASLC) staging committee has recently completed a decade of work devoted to updating the stage classification system for lung cancer. The IASLC has proposed revisions based on the evaluation of outcomes in an extensive worldwide database. This review outlines the changes in the tumor, node, metastasis (TNM) descriptors and stage groupings anticipated in the official new stage classification system for non-small-cell lung cancer with the forthcoming publication of the 7th Edition of the stage lassification.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.